AIMC Topic: Vascular Endothelial Growth Factors

Clear Filters Showing 1 to 2 of 2 articles

Myricitrin inhibits vascular endothelial growth factor-induced angiogenesis of human umbilical vein endothelial cells and mice.

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie Sep 17, 2020
In the present study, the protective effects of myricitrin against vascular endothelial growth factor (VEGF)-induced angiogenesis of vascular endothelial cells were characterized. Cells were induced with 50 ng/mL VEGF in the presence or absence of va...
Humans Biomarkers Animals Cell Line, Tumor Mice Angiogenesis Inhibitors Disease Models, Animal Apoptosis Flavonoids Human Umbilical Vein Endothelial Cells Caspases Matrix Metalloproteinases Neovascularization, Pathologic Neovascularization, Physiologic Vascular Endothelial Growth Factors Xenograft Model Antitumor Assays
View on PubMed DOI

Changes in systemic vascular endothelial growth factor levels after intravitreal injection of aflibercept in infants with retinopathy of prematurity.

Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie Dec 30, 2017
BACKGROUND: To investigate the levels of VEGF in the systemic circulation of patients with type 1 ROP who received intravitreal injections of 1 mg (0.025 mL) aflibercept (IVA) or 0.625 mg (0.025 mL) bevacizumab (IVB).
Humans Prospective Studies Biomarkers Prognosis Female Infant, Newborn Male Time Factors Enzyme-Linked Immunosorbent Assay Angiogenesis Inhibitors Treatment Outcome Follow-Up Studies Dose-Response Relationship, Drug Vascular Endothelial Growth Factors Intravitreal Injections Recombinant Fusion Proteins Receptors, Vascular Endothelial Growth Factor Retinopathy of Prematurity
View on PubMed DOI
Popular Topics
Recent Journals